Funding to accelerate the development of an innovative RNAi biocontrol technology to protect canola crops from crucifer and ...

One Harvard Square project got a win Monday in Cambridge, while another faced a setback. Officials have held a third change, ...

Get the latest analysis on Niagen Bioscience, including stock valuation, earnings update, and dilution risks. Learn if now is ...

Researchers at the University of Maine are theorizing that human beings may be in the midst of a major evolutionary ...

Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment rebound ...

Medicines Discovery Catapult (MDC) and Crown Bioscience have formed a strategic global collaboration to deliver an integrated translational biology platform for innovators developing ...

Washington University in St. Louis has plans to transform the historic Goodwill complex into a startup hub for bioscience ...

The study, recently published in the journal Antioxidants, shows that by upcycling damaged or discolored cherries destined for landfill into a natural powder rich in anthocyanins, food producers can ...

Regencell remains wildly overvalued despite an 80% stock drop, with no revenue, assets, or business activity to justify its ...

Two Cambridge-based biotechs, Camena Bioscience and Constructive Bio, have joined a project led by Germany's Max-Planck Institute of Molecular Plant Physiology to develop synthetic chloroplast genomes ...

Camena Bioscience, which is pioneering DNA synthesis technology from its HQ in Cambridge, has raised an unspecified amount of ...